المؤلفون: Groen K; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands., Smits F; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands., Nasserinejad K; HOVON Foundation Rotterdam The Netherlands.; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands., Levin MD; Department of Internal Medicine Albert Schweitzer Hospital Dordrecht The Netherlands., Regelink JC; Department of Internal Medicine Meander Medical Centre Amersfoort The Netherlands., Timmers GJ; Department of Internal Medicine Amstelland Hospital Amstelveen The Netherlands., de Waal EGM; Department of Internal Medicine Medical Centre Leeuwarden Leeuwarden The Netherlands., Westerman M; Department of Internal Medicine Northwest Clinics Alkmaar The Netherlands., Velders GA; Department of Internal Medicine Gelderse Vallei Ede The Netherlands., de Heer K; Department of Internal Medicine Flevoziekenhuis Almere The Netherlands., Leys RBL; Department of Internal Medicine Maasstad Hospital Rotterdam The Netherlands., van Kampen RJW; Department of Internal Medicine Zuyderland Hospital Sittard-Geleen The Netherlands., Stege CAM; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands.; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands., Seefat MR; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands., Nijhof IS; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Department of Internal Medicine Antonius Ziekenhuis Nieuwegein The Netherlands., van der Spek E; Department of Internal Medicine Rijnstate Hospital Arnhem The Netherlands., Klein SK; Department of Internal Medicine Meander Medical Centre Amersfoort The Netherlands.; Department of Hematology University Medical Center Groningen Groningen The Netherlands., van de Donk NWCJ; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands., Ypma PF; Department of Hematology Hagaziekenhuis, Den Haag The Netherlands., Zweegman S; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands.

المصدر: HemaSphere [Hemasphere] 2024 Jul 04; Vol. 8 (7), pp. e85. Date of Electronic Publication: 2024 Jul 04 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

المؤلفون: Groen K; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands., Stege CAM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands., Nasserinejad K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Innovative Statistical Consulting, Therapeutics Development Team, Cytel Inc., Massachusetts, USA., de Heer K; Department of Internal Medicine, Flevoziekenhuis, Almere, the Netherlands., van Kampen RJW; Department of Internal Medicine, Zuyderland Hospital, Sittard-Geleen, the Netherlands., Leys RBL; Department of Internal Medicine, Maasstad Hospital, Rotterdam, the Netherlands., Thielen N; Department of Internal Medicine, Diakonessenhuis, Utrecht, the Netherlands., Westerman M; Department of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands., Wu KL; Department of Hematology, ZNA Stuivenberg, Antwerpen, Belgium., Ludwig I; Department of Internal Medicine, Ziekenhuis Bernhoven, Uden, the Netherlands., Issa DE; Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, the Netherlands., Velders GA; Department of Internal Medicine, Gelderse Vallei, Ede, the Netherlands., Vekemans MC; Department of Hematology, Cliniques Universitaires Saint-Luc, UCL, Brussels, Belgium., Timmers GJ; Department of Internal Medicine, Amstelland Hospital, Amstelveen, the Netherlands., de Boer F; Department of Internal Medicine, Ikazia Hospital, Rotterdam, the Netherlands., Tick LW; Department of Internal Medicine, Maxima Medical Center, Eindhoven, the Netherlands., Verbrugge A; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Buitenhuis D; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Cunha SM; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van der Spek E; Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands., de Waal EGM; Department of Internal Medicine, Medisch Centrum Leeuwarden, Leeuwarden, the Netherlands., Sohne M; Department of Internal Medicine, Antonius Ziekenhuis, Nieuwegein, the Netherlands., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Nijhof IS; Department of Internal Medicine, Antonius Ziekenhuis, Nieuwegein, the Netherlands., Klein SK; Department of Internal Medicine, Meander Medical Center, Amersfoort, the Netherlands.; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., van de Donk NWCJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Ypma PF; Department of Internal Medicine, Haga Hospital, Den Haag, the Netherlands., Zweegman S; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands.

المصدر: EClinicalMedicine [EClinicalMedicine] 2023 Aug 29; Vol. 63, pp. 102167. Date of Electronic Publication: 2023 Aug 29 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

المؤلفون: Stege CAM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands. c.stege@amsterdamumc.nl., Nasserinejad K; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Klein SK; Department of Internal Medicine, Meander Medical Center, Amersfoort, the Netherlands.; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Timmers GJ; Department of Internal Medicine, Amstelland Hospital, Amstelveen, the Netherlands., Hoogendoorn M; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Ypma PF; Department of Hematology, Haga Hospital, The Hague, the Netherlands., Nijhof IS; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Velders GA; Department of Internal Medicine, Ziekenhuis Gelderse Vallei, Ede, the Netherlands., Strobbe L; Department of Internal Medicine, Gelre Hospital, Zutphen, the Netherlands., Durdu-Rayman N; Department of Internal Medicine-Hematology, Franciscus Hospital location Vlietland, Schiedam, the Netherlands., Westerman M; Department of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands., Davidis-van Schoonhoven MA; Department of Internal Medicine, Beatrix Hospital, Gorinchem, the Netherlands., van Kampen RJW; Department of Internal Medicine/Hematology, Zuyderland Medical Center, Sittard-Geleen, the Netherlands., Beeker A; Department of Internal Medicine, MBA Spaarne Gasthuis, Hoofddorp, the Netherlands., Koster A; Department of Internal Medicine, VieCuri Medical Center, Venlo, the Netherlands., Dijk AC; Department of Internal Medicine, St Jansdal Hospital, Harderwijk, the Netherlands., van de Donk NWCJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., van der Spek E; Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands., Leys RBL; Department of Hematology and Oncology, Maasstad Ziekenhuis, Rotterdam, the Netherlands., Silbermann MH; Department of Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands., Groen K; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., van der Burg-de Graauw NCHP; Department of Internal Medicine, Bravis ziekenhuis, Roosendaal, the Netherlands., Sinnige HAM; Department of Internal Medicine, Jeroen Bosch Ziekenhuis, 's Hertogenbosch, the Netherlands., van der Hem KG; Department of Internal Medicine, Zaans Medical Center, Zaandam, the Netherlands., Levenga H; Department of Internal Medicine, Groene Hart Hospital, Gouda, the Netherlands., Bilgin YM; Department of Internal Medicine, Admiraal de Ruijter Hospital, Goes, the Netherlands., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Zweegman S; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.

المصدر: Leukemia [Leukemia] 2021 Sep; Vol. 35 (9), pp. 2715-2719. Date of Electronic Publication: 2021 Feb 15.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Geriatric Assessment/*methods , Multiple Myeloma/*mortality, Aged ; Aged, 80 and over ; Follow-Up Studies ; Humans ; Multiple Myeloma/drug therapy ; Multiple Myeloma/pathology ; Prognosis ; Prospective Studies ; Survival Rate

المؤلفون: Zweegman S; Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands., Stege CAM; Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands., Haukas E; Stavanger University Hospital-Rogaland Hospital, Stavanger, Norway., Schjesvold FH; Oslo Myeloma Center, Oslo, Norway., Levin MD; Albert Schweitzer Hospital, Dordrecht, the Netherlands., Waage A; St Olavs Hospital and Norwegian University of Science, Trondheim, Norway., Leys RBL; Maasstad Hospital, Rotterdam, the Netherlands., Klein SK; Meander Medical Center, Amersfoort, the Netherlands., Szatkowski D; Førde Central Hospital, Førde, Norway., Axelsson P; Skanes University Hospital Lund, Scania, Sweden., Hieu Do T; Herlev Hospital, Herlev, Denmark., Knut-Bojanowska D; NU-Hospital, Uddevalla Hospital, Uddevalla, Sweden., van der Spek E; Rijnstate Hospital, Arnhem, the Netherlands., Svirskaite A; Aalborg Hospital, Aalborg, Denmark., Klostergaard A; Aarhus University Hospital, Aarhus, Denmark., Salomo M; Rigshospitalet Copenhagen, Copenhagen, Denmark., Blimark C; Sahlgrenska University Hospital, Gothenburg Sweden., Ypma PF; Haga Hospital, Den Haag, the Netherlands., Mellqvist UH; Sodra Alvsborgs Sjukhus Boras, Boras, Sweden., Poddighe PJ; Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands., Stevens-Kroef M; Radboud Medical Center, Nijmegen, the Netherlands., van de Donk NWCJ; Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands., Sonneveld P; Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Hansson M; Skanes University Hospital Lund, Scania, Sweden., van der Holt B; Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Abildgaard N; Department of Haematology, AgeCare, Odense University Hospital, Odense, Denmark.

المصدر: Haematologica [Haematologica] 2020 Dec 01; Vol. 105 (12), pp. 2879-2882. Date of Electronic Publication: 2020 Dec 01.

نوع المنشور: Clinical Trial, Phase II; Letter; Randomized Controlled Trial

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Multiple Myeloma*/diagnosis , Multiple Myeloma*/drug therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Boron Compounds ; Bortezomib/therapeutic use ; Dexamethasone/therapeutic use ; Glycine/analogs & derivatives ; Humans ; Stem Cell Transplantation ; Thalidomide/therapeutic use ; Transplantation, Autologous ; Treatment Outcome

المؤلفون: Doorduijn JK; Haematology, Erasmus MC Cancer Centre, Rotterdam, Netherlands., Zijlstra JM; Amsterdam UMC - Locatie VUMC, Amsterdam, Netherlands., Lugtenburg PJ; Erasmus MC Cancer Centre, Rotterdam, Netherlands., Kersten MJ; Haematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (lymphoma and myeloma Center), Amsterdam, Netherlands., Böhmer LH; Haematology, Haga Teaching Hospital, The Hague, USA., Minnema MC; Haematology, UMC Utrecht Cancer Centre, Utrecht, Netherlands., MacKenzie MA; UMCN, Nijmegen, Netherlands., van Marwijk Kooij R; Internal Medicine, Isala Clinic, Zwolle, Netherlands., de Jongh E; Albert Schweitzer Hospital Location Dordwijk, Dordrecht, Netherlands., Snijders TJF; Medisch Spectrum Twente, Enschede, Netherlands., de Weerdt O; Sint Antonius Hospital, Nieuwegein, Netherlands., van Gelder M; Maastricht University Medical Centre+, Maastricht, Netherlands., Hoogendoorn M; Medical Centre Leeuwarden, Leeuwarden, Netherlands., Leys RBL; Maasstad Ziekenhuis, Rotterdam, Netherlands., Kibbelaar RE; Department of Pathology, Pathology Friesland, Groningen, Netherlands., de Jong D; Amsterdam UMC - Locatie VUMC, Amsterdam, Netherlands., Chitu DA; Erasmus MC Cancer Center, Rotterdam, Netherlands., Van't Veer MB; Erasmus MC Cancer Centre, Rotterdam, Netherlands., Kluin-Nelemans HC; Haematology, University Medical Center Groningen, Groningen, Netherlands.

المصدر: British journal of haematology [Br J Haematol] 2020 Aug; Vol. 190 (3), pp. 385-393. Date of Electronic Publication: 2020 Mar 09.

نوع المنشور: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Bortezomib/*therapeutic use , Lymphoma, Mantle-Cell/*drug therapy, Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Carmustine/administration & dosage ; Combined Modality Therapy ; Cyclophosphamide/administration & dosage ; Cytarabine/administration & dosage ; Disease-Free Survival ; Doxorubicin/administration & dosage ; Etoposide/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Lymphoma, Mantle-Cell/therapy ; Male ; Melphalan/administration & dosage ; Middle Aged ; Netherlands ; Prednisone/administration & dosage ; Progression-Free Survival ; Remission Induction ; Rituximab/administration & dosage ; Transplantation, Autologous ; Treatment Failure ; Vincristine/administration & dosage ; Young Adult

SCR Protocol: BEAM regimen; CHOP protocol